Results 231 to 240 of about 196,937 (317)

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Invasive Right Anomalous Coronary Arteries Assessment: Intravascular Ultrasound and Adenosine vs Dobutamine Fractional Flow Reserve. [PDF]

JACC Adv
Stark AW, Ferroni A, Mathey-de-l'Endroit RL, Kakizaki R, Bigler MR, Biccirè FG, Ilic M, Shiri I, Haeberlin A, Siepe M, Windecker S, Räber L, Gräni C.   +12 more
europepmc   +1 more source

Role of Neuroimaging Before Coronary Angiography in Patients With Out‐of‐Hospital Cardiac Arrest

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients presenting following out‐of‐hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head‐trauma. Aims We investigated the impact and utility of pre‐coronary angiography CT‐Brain (CT‐B) in patients following OOHCA on clinical outcomes.
Edmond Wong, Kathryn Yu, Davide Tomassoni, Timothy Scully, Timothy Yeung, Jennifer Cooke, David Tong, Jaya Chandrasekhar, Jason Nogic   +8 more
wiley   +1 more source

Treating Women With Calcified Coronary Arteries Using Intravascular Lithotripsy: Primary Results of the EMPOWER CAD Study. [PDF]

J Soc Cardiovasc Angiogr Interv
McEntegart M, Gonzalo N, Shlofmitz R, Gunasekaran P, Gage A, Szerlip M, Davies R, Ahmad Y, Johnson M, West NEJ, Lansky AJ.   +10 more
europepmc   +1 more source

Frailty and Cardiovascular Events as Determined by Body Composition: A Systematic Review

Chronic Diseases and Translational Medicine, Volume 12, Issue 2, Page 113-120, June 2026.
Frailty phenotypes and risk of cardiovascular disease. Sarcopenic obese phenotype is associated with increased prevalence of cardiovascular risk factors and progression of metabolic syndrome, leading to cardiovascular events and cardiovascular mortality, while the Anorexic malnourished phenotype is associated with reduced prevalence of cardiovascular ...
Ishleen Oberoi, Shabnam Tariq, Kristian Arak, Mhd Alaa Aldin Al‐Haffar, Kyaw Thet, Ahmed H. Abdelhafiz   +5 more
wiley   +1 more source

Acute myocardial injury with normal coronary arteries in a young male: a case report of aortic dissection with rapidly progressive aortic regurgitation. [PDF]

J Cardiothorac Surg
Wei D, Hu Z, Zhang T, Kong M.
europepmc   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Pulmonary Embolism and Myocardial Infarction With Non-obstructive Coronary Arteries in Immune Thrombocytopenia: Unmasking Underlying Antiphospholipid Syndrome. [PDF]

Cureus
Shahzeb M, Naeem FJ, Naz K, Irfan M, Ahmad N, Rafiq N, Ul Haq I.   +6 more
europepmc   +1 more source

Population Pharmacokinetics of Ticagrelor during Veno‐Arterial ECMO in Acute Coronary Syndrome: Model‐Informed Dosing Simulations

Clinical Pharmacology &Therapeutics, EarlyView.
Although patients with acute coronary syndrome supported by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) have a high risk of thrombosis and bleeding, antiplatelet pharmacology in this setting is not well defined. This prospective observational study investigated the population pharmacokinetics of ticagrelor and its active metabolite AR ...
Soyoung Kang, Kyoung Lok Min, Seungwon Yang, Jongsung Hahn, Dasohm Kim, Byung Hak Jin, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang   +9 more
wiley   +1 more source

The patient journey in chronic coronary syndromes with/without obstructive coronary arteries. [PDF]

Eur Heart J Qual Care Clin Outcomes
La S, Tavella R, Wu J, Spertus JA, Pasupathy S, Girolamo O, Zeitz C, Worthley M, Arstall M, Sinhal A, Beltrame JF.   +10 more
europepmc   +1 more source